Advertisement
Loading...

Galapagos N.V. Sponsored ADR

LKFTNASDAQ
Healthcare
Biotechnology
$27.70
$-0.62(-2.17%)
U.S. Market is Open • 12:54
Advertisement

Galapagos N.V. Sponsored ADR Fundamental Analysis

Galapagos N.V. Sponsored ADR (LKFT) shows moderate financial fundamentals with a PE ratio of 3.28, profit margin of 46.83%, and ROE of 16.88%. The company generates $1.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Operating Margin57.14%
Cash Position159.69%
PEG Ratio-0.01
Current Ratio30.48

Areas of Concern

No major concerns flagged.
We analyze LKFT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 68.5/100 based on profitability, valuation, growth, and balance sheet metrics. The C+ grade reflects average fundamentals, with notable risks in certain areas.

Fundamental Health Score

C+
68.5/100

We analyze LKFT's fundamental strength across five key dimensions:

Efficiency Score

Excellent

LKFT demonstrates superior asset utilization.

ROA > 10%
14.49%

Valuation Score

Excellent

LKFT trades at attractive valuation levels.

PE < 25
3.28
PEG Ratio < 2
-0.01

Growth Score

Moderate

LKFT shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

LKFT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
30.48

Profitability Score

Moderate

LKFT maintains healthy but balanced margins.

ROE > 15%
16.88%
Net Margin ≥ 15%
46.83%
Positive Free Cash Flow
No

Key Financial Metrics

Is LKFT Expensive or Cheap?

P/E Ratio

LKFT trades at 3.28 times earnings. This suggests potential undervaluation.

3.28

PEG Ratio

When adjusting for growth, LKFT's PEG of -0.01 indicates potential undervaluation.

-0.01

Price to Book

The market values Galapagos N.V. Sponsored ADR at 0.49 times its book value. This may indicate undervaluation.

0.49

EV/EBITDA

Enterprise value stands at 4.17 times EBITDA. This is generally considered low.

4.17

How Well Does LKFT Make Money?

Net Profit Margin

For every $100 in sales, Galapagos N.V. Sponsored ADR keeps $46.83 as profit after all expenses.

46.83%

Operating Margin

Core operations generate 57.14 in profit for every $100 in revenue, before interest and taxes.

57.14%

ROE

Management delivers $16.88 in profit for every $100 of shareholder equity.

16.88%

ROA

Galapagos N.V. Sponsored ADR generates $14.49 in profit for every $100 in assets, demonstrating efficient asset deployment.

14.49%

Following the Money - Real Cash Generation

Operating Cash Flow

Galapagos N.V. Sponsored ADR generates limited operating cash flow of $-301.71M, signaling weaker underlying cash strength.

$-301.71M

Free Cash Flow

Galapagos N.V. Sponsored ADR generates weak or negative free cash flow of $-310.45M, restricting financial flexibility.

$-310.45M

FCF Per Share

Each share generates $-4.71 in free cash annually.

$-4.71

FCF Yield

LKFT converts -19.37% of its market value into free cash.

-19.37%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

3.28

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.01

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.49

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.53

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.002

vs 25 benchmark

Current Ratio

Current assets to current liabilities

30.48

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.17

vs 25 benchmark

ROA

Return on assets percentage

0.14

vs 25 benchmark

ROCE

Return on capital employed

0.18

vs 25 benchmark

How LKFT Stacks Against Its Sector Peers

MetricLKFT ValueSector AveragePerformance
P/E Ratio3.2829.38 Better (Cheaper)
ROE16.88%739.00% Weak
Net Margin46.83%-53619.00% (disorted) Strong
Debt/Equity0.000.39 Strong (Low Leverage)
Current Ratio30.484.03 Strong Liquidity
ROA14.49%-20116.00% (disorted) Strong

LKFT outperforms its industry in 5 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Galapagos N.V. Sponsored ADR's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ